These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 10770805

  • 1. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M, Wucherpfennig KW, Cannella B, Hansen BE, Svejgaard A, Pyrdol J, Ditzel H, Raine C, Engberg J, Fugger L.
    J Exp Med; 2000 Apr 17; 191(8):1395-412. PubMed ID: 10770805
    [Abstract] [Full Text] [Related]

  • 2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L.
    Nat Genet; 1999 Nov 17; 23(3):343-7. PubMed ID: 10610182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y, Li H, Martin R, Mariuzza RA.
    J Mol Biol; 2000 Nov 24; 304(2):177-88. PubMed ID: 11080454
    [Abstract] [Full Text] [Related]

  • 6. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW, Hafler DA, Strominger JL.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8896-900. PubMed ID: 7568039
    [Abstract] [Full Text] [Related]

  • 7. Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses.
    Fridkis-Hareli M, Stern JN, Fugger L, Strominger JL.
    Hum Immunol; 2001 Aug 12; 62(8):753-63. PubMed ID: 11476898
    [Abstract] [Full Text] [Related]

  • 8. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
    Mukku PV, Passmore D, Phan D, Nag B.
    Mol Immunol; 1995 Jun 12; 32(8):555-64. PubMed ID: 7541890
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
    Chang JW, Mechling DE, Bächinger HP, Burrows GG.
    J Biol Chem; 2001 Jun 29; 276(26):24170-6. PubMed ID: 11319230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.
    Hansen BE, Nielsen CH, Madsen HO, Ryder LP, Jakobsen BK, Svejgaard A.
    Tissue Antigens; 2011 Mar 29; 77(3):229-34. PubMed ID: 21299528
    [Abstract] [Full Text] [Related]

  • 18. Anergy induction by dimeric TCR ligands.
    Appel H, Seth NP, Gauthier L, Wucherpfennig KW.
    J Immunol; 2001 Apr 15; 166(8):5279-85. PubMed ID: 11290814
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.